Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Does the Decline in Life Settlement Provider Numbers Impact Investors?

    Secondary Life Markets August 13, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The European Life Settlement Association (ELSA, publisher of Life Risk News) produced an update to its Licensed Provider Matrix (LPM) recently, with the headline being that providers at the smaller end of the market continued to exit it in the past 12 months.

    ELSA’s now annual exercise to map the landscape of licensed life settlement providers – the buyer on record of life insurance policies in the secondary market – identified 31 firms that were licensed in at least one state at the beginning of this year, down 7 from 38 last year, or 18%.

    That is a reasonably sized decline of market participants by any standard. But that does not tell the full story, because all but one of those providers which exited the market held only one licence. Indeed, there was an increase in the collective total number of licenses to 710, up from last year’s 705.

    The life settlement provider landscape has been in consolidation – generally – for many years.

    Back in 2010, the United States Government Accountability Office (GAO) published LIFE INSURANCE SETTLEMENTS: Regulatory Inconsistencies May Pose a Number of Challenges, a deep dive into the market in which states were asked to provide a considerable amount of information about their life settlement markets, including the number of providers currently licensed in their state: Texas alone had 62 firms (p.89) and four other states – Connecticut, Hawaii, Kentucky, North Carolina – each had more than 40.

    Times were different back then. Secondary market activity was much higher (in 2009, the total face value transacted in the secondary market was $7.6bn, according to the annual life settlement report published by Conning) – so it makes sense for there to have been more providers purchasing policies.

    But in the past 15 years, there has been something of a maturation in the space.

    “I think there has been something of an institutionalisation of the life settlement market in the last half decade or so,” said Rob Haynie, Managing Director at Life Insurance Settlements.

    “Most of the firms that are active in the space now are larger and more experienced than they were before, and as they have grown, they have taken more market share. There has been some M&A but some of the smaller firms probably either just stopped, or retired, as the larger, institutional firms grew.”

    The reality of exactly how many providers are truly ‘active’ depends on how it is defined, but in some circles, the number of firms in the market on a weekly basis could be even less. Indeed, 10 firms are licensed in 10 or fewer territories, hardly enough to be considered a national player. Indeed, The Life Settlements Report, part of The Deal, publishes an annual league table of transactions completed by life settlement providers and only 15 firms completed more than 10 deals in 2024.

    Buying a life insurance policy on the secondary market is more akin to buying real estate than it is to buying stocks. The process is involved, and often lengthy. So, it could be argued, therefore, that the reality of the life settlement provider market is that there are around 20 firms participating in it in a meaningful way; that is the number of firms in the LPM this year that are currently licensed in 20 or more states. And it may be that the market is even more oligopolistic than might appear on the surface.

    “It is fairly common knowledge for anyone who is active in the life settlement market now to know which provider is purchasing more policies than another. I’d say that probably 70% or so of all deals in the secondary market are transacted by just a handful of companies,” said Haynie.

    So, what does this all mean for the investors in life settlement funds? Some might see a shrinking list of active providers and become concerned that fewer participants might mean fewer opportunities for their asset manager to buy policies.

    Not necessarily. The life settlement market likes to say (with some justification) that it delivers uncorrelated returns to its investors, and there is a similar lack of correlation here, too.

    “Buying opportunities are only created when policyholders learn about the option to sell and begin the sales process, which itself is driven by consumer awareness, broker and provider marketing, and adviser education. Capital allocators rely on their asset managers’ relationships with active providers and brokers, not the sheer number of licensed names on a regulator’s list. As awareness grows, volume can rise even if provider count falls,” said Rainer Gruenig, CEO at Plenum Investments.

    Another nuance to this year’s LPM is that the 20 providers that are licensed in 20 or more states is actually one higher than last year. Add to that the fact that the other 19 have maintained at least 20 licenses in the 3 years since ELSA launched its LPM, the argument that the licensed provider market has matured over the years seems to hold water.

    What will happen next year is anyone’s guess. Some states license life settlement providers for multiple years, so it is possible that some firms that appear in the LPM this year have not completed any transactions recently and the market may see a further contraction in future editions of the LPM. And a regulator might throw in a curveball – good or bad.

    That is nothing more than speculation (at present). But for Gruenig, the current market infrastructure provides – pun intended – plenty of opportunities for asset managers to build a diversified portfolio of policies.

    “There is deal flow in the market from a variety of providers, and they bring a wide range of them to market, whether that be life expectancy, state domicile, health status, and/or face value. The fact there are less of them now than 15 years ago does not necessarily have to be a disadvantage for investors, because what is more important is their professionalism.”

    2025 - August Life Settlements Longevity Risk Volume 4 Issue 8 – August 2025
    Share. Twitter LinkedIn Email

    Related Posts

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026By Mark McCord
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026By Greg Winterton

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026By ArentFox Schiff

    Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

    July 22, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.